Please login to the form below
Indoco and Watson Pharma in deal
Indian company Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market
Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market.
Shares of the Mumbai-based Indoco surged 4.95 per cent on the Bombay Stock Exchange after the announcement.
Under this deal, Indoco will develop, manufacture and supply a number of products that currently have yearly sales of $679m.
Indoco's chairman and managing director Suresh G Kare has said it is a remarkable achievement to be out-licensing technology to a company of Watson's scale.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
-
Senior Account Executive
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Manager
-
Competitive Salary
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
-
Associate Account Director
-
Competitive Salary
-
Senior Medical Writer
-
Competitive Salary
-
Medical Editor
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Roche’s Ocrevus shows significant benefit in early-stage MS patients
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Leaders in Pharma: Samir Vattompadam
- Building Better Access to Pediatric Care Through Telehealth
- Building trust through sustainability communications
- Healthware Group acquires London-headquartered consultancy SWM
- Lucid Group promotes Clare Reynolds to Director of Business Development and Commercial Integration
- Are you ready for the digital health revolution?
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Are you ready for the digital health revolution?
- In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
- #DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
- Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
- Empowering patients empowers results
- Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Quick links
Infographics
